166 related articles for article (PubMed ID: 37855419)
1. Radiofrequency ablation for thyroid Bethesda III nodules: preliminary results.
Chiang PL; Luo SD; Chang YH; Chou CK; Chi SY; Chen YF; Lin WC
Eur Thyroid J; 2023 Dec; 12(6):. PubMed ID: 37855419
[TBL] [Abstract][Full Text] [Related]
2. Clinico-cytopathological subcategorization in thyroid nodules of atypia of undetermined significance/follicular lesion of undetermined significance using the TIRADS and Bethesda classifications.
Babajani A; Rahmani S; Raoufi M; Eidgahi ES; Dastjerdi AV; Behfarnia P; Khalili S; Moghaddam NA
Front Endocrinol (Lausanne); 2023; 14():1135196. PubMed ID: 37313444
[TBL] [Abstract][Full Text] [Related]
3. Radiofrequency ablation is an effective treatment for Bethesda III thyroid nodules without genetic alterations.
Fugazzola L; Deandrea M; Borgato S; Dell'Acqua M; Retta F; Mormile A; Carzaniga C; Gazzano G; Pogliaghi G; Muzza M; Persani L
Eur Thyroid J; 2024 Jun; 13(3):. PubMed ID: 38657647
[TBL] [Abstract][Full Text] [Related]
4. Thyroid nodules with atypia or follicular lesions of undetermined significance (Bethesda Category III): importance of ultrasonography and cytological subcategory.
Rosario PW
Thyroid; 2014 Jul; 24(7):1115-20. PubMed ID: 24684285
[TBL] [Abstract][Full Text] [Related]
5. Volume reduction rate of radiofrequency ablation in ≤ 2 cm Bethesda IV thyroid nodules.
Dong Y; Zhan W; Zhou J; Li N; Liu Z; Xia S; Ni X; Liu J; Zhang J; Xu S; Yang Z; Hua Q
Eur Radiol; 2024 Mar; 34(3):1597-1604. PubMed ID: 37665388
[TBL] [Abstract][Full Text] [Related]
6. Core-needle biopsy is more useful than repeat fine-needle aspiration in thyroid nodules read as nondiagnostic or atypia of undetermined significance by the Bethesda system for reporting thyroid cytopathology.
Na DG; Kim JH; Sung JY; Baek JH; Jung KC; Lee H; Yoo H
Thyroid; 2012 May; 22(5):468-75. PubMed ID: 22304417
[TBL] [Abstract][Full Text] [Related]
7. Malignancy rate in thyroid nodules classified as Bethesda category III (AUS/FLUS).
Ho AS; Sarti EE; Jain KS; Wang H; Nixon IJ; Shaha AR; Shah JP; Kraus DH; Ghossein R; Fish SA; Wong RJ; Lin O; Morris LG
Thyroid; 2014 May; 24(5):832-9. PubMed ID: 24341462
[TBL] [Abstract][Full Text] [Related]
8. Approach to Bethesda system category III thyroid nodules according to US-risk stratification.
Kim J; Shin JH; Oh YL; Hahn SY; Park KW
Endocr J; 2022 Jan; 69(1):67-74. PubMed ID: 34408101
[TBL] [Abstract][Full Text] [Related]
9. ACR TI-RADS and ATA US scores are helpful for the management of thyroid nodules with indeterminate cytology.
Barbosa TLM; Junior COM; Graf H; Cavalvanti T; Trippia MA; da Silveira Ugino RT; de Oliveira GL; Granella VH; de Carvalho GA
BMC Endocr Disord; 2019 Oct; 19(1):112. PubMed ID: 31664992
[TBL] [Abstract][Full Text] [Related]
10. Risk Stratification of Thyroid Nodules With Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance (AUS/FLUS) Cytology Using Ultrasonography Patterns Defined by the 2015 ATA Guidelines.
Lee JH; Han K; Kim EK; Moon HJ; Yoon JH; Park VY; Kwak JY
Ann Otol Rhinol Laryngol; 2017 Sep; 126(9):625-633. PubMed ID: 28719972
[TBL] [Abstract][Full Text] [Related]
11. Risk factors associated with malignancy and with triage to surgery in thyroid nodules classified as Bethesda category III (AUS/FLUS).
Kuru B; Atmaca A; Tarim IA; Kefeli M; Topgul K; Yoruker S; Elmali M; Danaci M
Eur J Surg Oncol; 2016 Jan; 42(1):87-93. PubMed ID: 26527545
[TBL] [Abstract][Full Text] [Related]
12. ThyroSeq v3 for Bethesda III and IV: An institutional experience.
Desai D; Lepe M; Baloch ZW; Mandel SJ
Cancer Cytopathol; 2021 Feb; 129(2):164-170. PubMed ID: 33030808
[TBL] [Abstract][Full Text] [Related]
13. Malignancy risk and characteristics of thyroid nodules with two consecutive results of atypia of undetermined significance or follicular lesion of undetermined significance on cytology.
Park VY; Kim EK; Kwak JY; Yoon JH; Moon HJ
Eur Radiol; 2015 Sep; 25(9):2601-7. PubMed ID: 25740802
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic Performance of Ultrasound Patterns by K-TIRADS and 2015 ATA Guidelines in Risk Stratification of Thyroid Nodules and Follicular Lesions of Undetermined Significance.
Hong HS; Lee JY
AJR Am J Roentgenol; 2019 Aug; 213(2):444-450. PubMed ID: 31039023
[No Abstract] [Full Text] [Related]
15. Follow-up of atypia and follicular lesions of undetermined significance in thyroid fine needle aspiration cytology.
Dincer N; Balci S; Yazgan A; Guney G; Ersoy R; Cakir B; Guler G
Cytopathology; 2013 Dec; 24(6):385-90. PubMed ID: 23078633
[TBL] [Abstract][Full Text] [Related]
16. Thyroid cytology-nuclear versus architectural atypia within the "Atypia of undetermined significance/follicular lesion of undetermined significance" Bethesda category have significantly different rates of malignancy.
Gan TR; Nga ME; Lum JH; Wong WM; Tan WB; Parameswaran R; Ngiam KY
Cancer Cytopathol; 2017 Apr; 125(4):245-256. PubMed ID: 28192631
[TBL] [Abstract][Full Text] [Related]
17. Risk of malignancy according to sub-classification of the atypia of undetermined significance or follicular lesion of undetermined significance (AUS/FLUS) category in the Bethesda system for reporting thyroid cytopathology.
Kim SJ; Roh J; Baek JH; Hong SJ; Shong YK; Kim WB; Song DE
Cytopathology; 2017 Feb; 28(1):65-73. PubMed ID: 27245883
[TBL] [Abstract][Full Text] [Related]
18. Differences in the ultrasonographic appearance of thyroid nodules after radiofrequency ablation.
Wu MH; Chen KY; Chen A; Chen CN
Clin Endocrinol (Oxf); 2021 Sep; 95(3):489-497. PubMed ID: 33938024
[TBL] [Abstract][Full Text] [Related]
19. Thyroid nodules classified as atypia or follicular lesions of undetermined significance deserve further research: Analysis of 305 surgically confirmed nodules.
Turkyilmaz S; Ulusahin M; Celebi B; Cekic AB; Mungan S; Kucuktulu U; Tasdelen A; Guner A; Cinel A
Cytopathology; 2017 Oct; 28(5):391-399. PubMed ID: 28714532
[TBL] [Abstract][Full Text] [Related]
20. Ultrasound is helpful to differentiate Bethesda class III thyroid nodules: A PRISMA-compliant systematic review and meta-analysis.
Gao LY; Wang Y; Jiang YX; Yang X; Liu RY; Xi XH; Zhu SL; Zhao RN; Lai XJ; Zhang XY; Zhang B
Medicine (Baltimore); 2017 Apr; 96(16):e6564. PubMed ID: 28422844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
